Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | HTR4 | Q13639 | 5/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5215761 | 0.90 | ALOX15 (0.52) | SMN1; SMN2ALDH1A1GAAHTR4ALOX15 | |
| SCHEMBL5216679 | 0.89 | SMN1; SMN2 (0.49) | SMN1; SMN2ALDH1A1GAAHTR4ALOX15 | |
| SCHEMBL5215957 | 0.89 | SMN1; SMN2 (0.60) | SMN1; SMN2ALDH1A1GAAHTR4ALOX15 | |
| SCHEMBL5217099 | 0.87 | HTR4 (0.48) | SMN1; SMN2ALDH1A1GAAHTR4ALOX15 | |
| SCHEMBL5214681 | 0.86 | HTR4 (0.46) | SMN1; SMN2ALDH1A1GAAHTR4ALOX15 | |
| SCHEMBL5216773 | 0.86 | SMN1; SMN2 (0.42) | SMN1; SMN2ALDH1A1GAAHTR4ALOX15 | |
| SCHEMBL5306262 | 0.85 | HTR4 (0.46) | SMN1; SMN2ALDH1A1GAAHTR4ALOX15 | |
| SCHEMBL5219357 | 0.83 | HTR4 (0.50) | SMN1; SMN2ALDH1A1GAAHTR4ALOX15 | |
| SCHEMBL5215111 | 0.82 | HTR4 (0.46) | ALDH1A1HTR4 | |
| SCHEMBL5304656 | 0.80 | ALDH1A1 (0.52) | SMN1; SMN2ALDH1A1GAAHTR4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1112270-B1 | DIHYDROBENZODIOXINE CARBOXAMIDE AND KETONE DERIVATIVES AS 5-HT4 RECEPTOR ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2007-03-21 | — | — | EP | claimed |
| EP-1112270-B1 | DIHYDROBENZODIOXINE CARBOXAMIDE AND KETONE DERIVATIVES AS 5-HT4 RECEPTOR ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2007-03-21 | — | — | EP | disclosed |
| EP-1112270-A1 | DIHYDROBENZODIOXINE CARBOXAMIDE AND KETONE DERIVATIVES AS 5-HT4 RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2001-07-04 | — | — | EP | disclosed |
| US-6172062-B1 | ANTISEROTONIN AGENTS; GASTROINTESTINAL DISORDERS; CARDIOVASCULAR DISORDERS; NERVOUS SYSTEM DISORDERS | SYNTEX (USA) LLC | 2001-01-09 | — | — | US | disclosed |
| WO-2000015636-A1 | DIHYDROBENZODIOXINE CARBOXAMIDE AND KETONE DERIVATIVES AS 5-HT4 RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2000-03-23 | — | — | WO | disclosed |